1. Introduction
===============

Ionotropic glutamate receptors are responsible for glutamate-mediated excitatory transmission in mammalian brain \[[@B1-molecules-18-08799],[@B2-molecules-18-08799]\]. 5HT~2A~ and 5HT~1A~ receptors are probably the most prominent subtypes of the exuberant family of serotonin receptors. Several modeling studies have dealt with these two targets \[[@B3-molecules-18-08799],[@B4-molecules-18-08799],[@B5-molecules-18-08799],[@B6-molecules-18-08799],[@B7-molecules-18-08799],[@B8-molecules-18-08799],[@B9-molecules-18-08799],[@B10-molecules-18-08799]\], most of them based on SAR considerations by using solely synthetic drugs as ligands. Until now structural variants of the natural ligand 5-OH-tryptamine were not investigated in great detail. In this work, potencies of tryptamine derivatives (Ts) as inhibitors of \[^3^H\]MK-801 \[[@B11-molecules-18-08799]\] binding (in the absence or presence of a stimulating spermine concentration) and as inhibitors of \[^3^H\]ketanserin \[[@B12-molecules-18-08799]\], and \[^3^H\]8-OH-DPAT \[[@B13-molecules-18-08799]\] binding to rat brain membranes were used to generate and evaluate holographic quantitative structure activity relationship (HQSAR) models.

The fragment-based HQSAR turned out to be a promising tool for establishing a relationship between the structure of a compound and its biological activities. It is a modern QSAR technique that requires no explicit 3D information for the ligands (e.g., structure, physicochemical descriptors, conformation and molecular alignment) \[[@B14-molecules-18-08799]\]. As it is done with 3D-QSAR techniques, such as CoMFA and CoMSIA, HQSAR as well could easily and rapidly generate QSAR models with high predictive value for both small and large data sets \[[@B15-molecules-18-08799]\].

2. Results and Discussion
=========================

Basically, this analysis involves three main steps: (1) generation of structural fragments for each T; (2) the encoding of these fragments into a molecular hologram; (3) the statistical generation of PLS QSAR models \[[@B16-molecules-18-08799]\]. In our studies, the influence of the fragment distinction parameters on the statistical values of our models was investigated. Thus, several combinations of fragment parameters were considered during the QSAR modeling runs.

2.1. HQSAR of Ts as Inhibitors of \[^3^H\]MK-801 Binding
--------------------------------------------------------

A set of 64 Ts were used to establish a HQSAR model for the inhibition of \[^3^H\]MK-801 binding. The optimum number of components was selected for each fragment parameter combination. We have calculated 63 parameter combinations. Only a set of six combinations is given in [Table 1](#molecules-18-08799-t001){ref-type="table"} (the others show less significant results).

The donor & acceptor parameter (model 6) seems to play a certain role for inhibitory activity, while hydrogen atoms (model 4) and chirality (model 5) show a small q^2^. By adding more fragment parameters to the model, continuously further improvements were observed (models 15, 28, 50, 58, 63). Model 63, based on a combination of all fragments gave the best result (q^2^ = 0.632 and r^2^ = 0.855). This model was derived using six fragment distinctions, with six being the optimum number of PLS components. The plot of pIC~50~ values of all molecules predicted by model 63 *versus* experimental values is shown in [Figure 1](#molecules-18-08799-f001){ref-type="fig"}A. As can be seen, the predicted values are in good agreement with experimental values thus entailing a model with good correlative and predictive abilities.

The HQSAR-based fragmentation of a molecule into atoms allows to evaluate which of them are correlated with the biological activity of the molecule. HQSAR models can be graphically represented in the form of contribution maps where the color of each molecular fragment reflects the contribution of an atom or a small number of atoms to the activity of the molecule under study. The colors at the red end of the spectrum (*i.e.*, red, red-orange, and orange) reflect unfavorable (negative) contributions, while colors at the blue end (*i.e.*, yellow, green-blue and blue) indicate favorable (positive) contributions. Atoms with intermediate contributions are colored in white. The common backbones are colored cyan.
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###### 

Regression summary of HQSAR models of various combinations of fragment distinction parameters for 64 Ts as inhibitors of \[^3^H\]MK-801 binding. A, atoms; B, bonds; C, connections; H, hydrogen atoms; CH, chirality; DA, donor & acceptor; q^2^, LOO cross validated correlation coefficient; r^2^, non-cross-validated correlation coefficient; SE, standard error of estimate; ensemble: average value of ensemble q^2^ \*; BL, best hologram length; n, number of components used in the PLS analysis.

  Model   Field           n   q^2^    r^2^    SE      Ensemble   BL
  ------- --------------- --- ------- ------- ------- ---------- -----
  6       DA              3   0.304   0.487   0.437   0.257      307
  15      B/DA            3   0.451   0.591   0.390   0.365      59
  28      A/C/DA          6   0.475   0.856   0.238   0.375      353
  50      A/C/CH/DA       5   0.460   0.820   0.263   0.339      353
  58      A/B/C/H/DA      6   0.539   0.832   0.256   0.398      61
  63      A/B/C/H/CH/DA   6   0.632   0.855   0.238   0.399      61

\* For each hologram length, a model could be established. The collection of these models comprises the ensemble.

![Plot of predicted *versus* observed pIC~50~ value of Ts inhibiting (**A**) \[^3^H\]MK-801 binding (model 63, [Table 1](#molecules-18-08799-t001){ref-type="table"}) and (**B**) \[^3^H\]MK-801 binding in presence of 30 µM spermine (model 63, [Table 2](#molecules-18-08799-t002){ref-type="table"}).](molecules-18-08799-g001){#molecules-18-08799-f001}

A red color code at position 5 was returned for compounds without substituent at this position: thus, there is an obvious demand for an appropriate substitution at this particular carbon (compound **1**). Methyl groups at positions 6, 7, α or N, respectively, are strongly disfavored. Several 2-Me-Ts with different alkyl substituents at position 5 (compounds **19**--**22**) contribute favorably to activity as indicated by the green and yellow color (compound **20** being the most potent, [Figure 2](#molecules-18-08799-f002){ref-type="fig"}A). Halogen substituents as well, especially fluorine (compound **47**), are positively contributing to the activity. On the other hand, hydroxy- or methoxy-substituents exert a weak to strong negative contribution. For instance, compound **40**, the least active compound of the series, carries a hydroxyl group at position 5 and a methyl group at position α, a highly unfavorable substituent pattern ([Figure 2](#molecules-18-08799-f002){ref-type="fig"}C).

![HQSAR contribution of molecular fragments to the inhibition of \[^3^H\]MK-801 binding; 2 examples for potent compounds **20** (**A**) and **58** (**B**), with favorable substituents in yellow and very favorable ones in green and 2 examples for weak compounds **40** (**C**) and **43** (D), with unfavorable substituents in orange and very unfavorable ones in red are given.](molecules-18-08799-g002){#molecules-18-08799-f002}

Alkyl substituents at position 7 are exerting a negative effect whereas halogens at this position are tolerated. Halogen substituents at positions 5 and 7 (compound **58**, [Figure 2](#molecules-18-08799-f002){ref-type="fig"}B) are positively contributing to activity. These results imply that electronegative substituents at position 5 and 7 enhance activity. Compound **43**, being one of the least active compounds, carries methyl groups at positions 2, 4 and 7. The decisive negative influence comes from the methyl group at position 7 ([Figure 2](#molecules-18-08799-f002){ref-type="fig"}D).

2.2. HQSAR of \[^3^H\]MK-801 Binding in the Presence of Spermine
----------------------------------------------------------------

As reported previously \[[@B17-molecules-18-08799]\] the polyamine spermine reduces the potency of most Ts as inhibitors of \[^3^H\]MK-801 binding. This effect may involve the recently described GluN1/GluN2B interface mediating polyamine stimulation of the NMDA receptor \[[@B18-molecules-18-08799]\]. We have calculated 63 parameter combinations. Only a set of 6 combinations is given in [Table 2](#molecules-18-08799-t002){ref-type="table"} (the others show less significant results).

In an effort to obtain the best model, combinations of different fragments were considered. The parameter hydrogen atoms (model 4) and chirality (model 5) correlate badly with the activity. On the other hand, connections (model 3) play a certain role. Furthermore, model 63, based on combination of all fragments gave the best result (q^2^ = 0.600 and r^2^ = 0.803). This result does not surprise as the above studies have shown that a combination of all fragment parameters give the best model for \[^3^H\]MK-801 binding. The plot of pIC~50~ values of all molecules predicted by model-63 *versus* experimental values are reported in [Figure 1](#molecules-18-08799-f001){ref-type="fig"}B.

molecules-18-08799-t002_Table 2

###### 

Regression summary of HQSAR models combined with various fragment distinction parameters for the 64 Ts as inhibitors of \[^3^H\]MK-801 binding in the presence of 30 µM of spermine ^a^.

  Model   Field           n   q^2^    r^2^    SE      Ensemble   BL
  ------- --------------- --- ------- ------- ------- ---------- -----
  3       C               6   0.292   0.640   0.366   0.207      61
  9       A/H             3   0.356   0.535   0.405   0.292      353
  28      A/C/DA          6   0.453   0.831   0.250   0.326      353
  51      A/H/CH/DA       3   0.425   0.587   0.382   0.362      401
  58      A/B/C/H/DA      6   0.525   0.791   0.278   0.357      61
  63      A/B/C/H/CH/DA   6   0.600   0.803   0.270   0.366      61

^a^ Abbreviations as in [Table 1](#molecules-18-08799-t001){ref-type="table"}.

The fragment contribution pattern in the presence of spermine is similar to that in its absence. The same model 63 proved as the best one. While it was remarkable that in the presence of spermine substituents in position 5 were less advantageous than without spermine (especially in the case of substituents larger than methyl, see compounds **14**, **16**, **20**, **22**, **23**, **25**, **29**), all these attenuated IC~50~ values were above 10 µM, more than 2/3 even above 100 µM. Therefore, it may not be justified to elaborate on these results in any more detail.

2.3. HQSAR of Ts as Inhibitors of \[^3^H\]ketanserin Binding
------------------------------------------------------------

We have calculated 63 parameter combinations for the 64 Ts as inhibitors of \[^3^H\]ketanserin binding. Only a set of seven combinations is given in [Table 3](#molecules-18-08799-t003){ref-type="table"} (the others show less significant results).

Model 3 ("connections") yielded the most significant result. Adding hydrogen atoms (model 16) or chirality (model 17) did not improve the model. Also, the best combination of three descriptors, atoms, hydrogen atoms and donor & acceptor (A/H/DA, model 30) achieved only a small improvement. The best statistical result was obtained by model 58 which combines five descriptors (q^2^ = 0.489 and r^2^ = 0.738). The plot of pIC~50~ values of 59 Ts derivatives predicted by model 58-5 *versus* experimental values is reported in [Figure 3](#molecules-18-08799-f003){ref-type="fig"}A.

molecules-18-08799-t003_Table 3

###### 

Regression summary of HQSAR models combined with various fragment distinction parameters for the 64 Ts as inhibitors of \[^3^H\]ketanserin binding. ^a^

  Model   Field           n   q^2^    r^2^    SE      Ensemble   BL
  ------- --------------- --- ------- ------- ------- ---------- -----
  3       C               6   0.423   0.779   0.258   0.355      199
  16      C/H             6   0.423   0.779   0.258   0.355      199
  17      C/CH            6   0.423   0.779   0.258   0.355      199
  30      A/H/DA          5   0.456   0.768   0.262   0.313      97
  56      C/H/CH/DA       6   0.455   0.842   0.219   0.334      61
  58      A/B/C/H/DA      3   0.489   0.738   0.274   0.341      199
  63      A/B/C/H/CH/DA   5   0.465   0.794   0.247   0.328      199

^a^ Abbreviations as in [Table 1](#molecules-18-08799-t001){ref-type="table"}.

![Plot of predicted *versus* observed pIC~50~ value of Ts inhibiting the binding of (**A**) \[^3^H\]ketanserin (model 58, [Table 3](#molecules-18-08799-t003){ref-type="table"}); and (**B**) \[^3^H\]8-OH-DPAT (model 15, [Table 4](#molecules-18-08799-t004){ref-type="table"}).](molecules-18-08799-g003){#molecules-18-08799-f003}

A fragment contribution pattern including substituents in positions 1, 4 or 5 was favorable for high activity. A methyl substitution at the positions 6 and 7 was less advantageous, resulting in red and orange color coding (e.g., compound **42**, [Figure 4](#molecules-18-08799-f004){ref-type="fig"}D). However, combined substitution at positions 4, 5, 6 or 7 with methyl and halogen is tolerated. Substituents like CN, OH, OMe and CONH~2~ at position 5 are strongly disfavored (compound **29**, [Figure 4](#molecules-18-08799-f004){ref-type="fig"}C), while a halogen substituent at this position (*i.e*., compound **14**, [Figure 4](#molecules-18-08799-f004){ref-type="fig"}A) moderately contributed to activity. As we mentioned previously, also in this case the lack of coloring in A ([Figure 4](#molecules-18-08799-f004){ref-type="fig"}) it due to a slight advantage compared to compound **2** (orange in position 2 and 7). Combined with a 2-methyl substituent, halogens at positions 4, 5, 6 and 7 improve the inhibitory activity. Moreover, combined with 2-Me-substituted Ts alkyl groups can be at positioned at carbon 5 but not at carbon 7. The fragment contributions to the activity of molecule **53** (the most potent at this target) is displayed in [Figure 4](#molecules-18-08799-f004){ref-type="fig"}B.

![HQSAR contribution of molecular fragments to the inhibition of \[^3^H\]ketanserin binding; 2 examples for highly active compounds **14** (**A**) and **53** (**B**) and 2 examples for weak compounds, **29** (**C**) and **42** (**D**) are given.](molecules-18-08799-g004){#molecules-18-08799-f004}

2.4. HQSAR of Ts as Inhibitors of \[^3^H\]8-OH-DPAT Binding
-----------------------------------------------------------

We have calculated 63 parameter combinations for 47 Ts as inhibitors of \[^3^H\]8-OH-DPAT binding. Only a set of six combinations is given in [Table 4](#molecules-18-08799-t004){ref-type="table"} (the others show less significant results).

The fraction parameter connections (model 3) is very important, while a combination of the parameters bonds and donor & acceptor (model 15) is still improving the correlation. Using five (model 61) or all parameters (model 63) resulted in lower correlations. The best statistical result among all models was obtained for model 15 (q^2^ = 0.626 and r^2^ = 0.822). The plot of pIC~50~ values of all molecules predicted by model15 *versus* experimental values is shown in [Figure 3](#molecules-18-08799-f003){ref-type="fig"}B.
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###### 

Regression summary of HQSAR models combined with various fragment distinction parameters for 47 Ts as inhibitors of \[^3^H\]8-OH-DPAT binding. ^a^

  Model   Field           n   q^2^    r^2^    SE      ensemble   BL
  ------- --------------- --- ------- ------- ------- ---------- -----
  3       C               4   0.575   0.753   0.610   0.521      83
  15      B/DA            4   0.626   0.822   0.519   0.532      257
  36      B/H/DA          4   0.626   0.822   0.519   0.532      257
  55      B/H/CH/DA       4   0.626   0.821   0.519   0.533      257
  61      A/C/H/CH/DA     5   0.574   0.830   0.512   0.436      71
  63      A/B/C/H/CH/DA   4   0.530   0.792   0.560   0.445      97

^a^ Abbreviations as in [Table 1](#molecules-18-08799-t001){ref-type="table"}.

Mono-alkylation (each position possible) has not much influence on activity. Two- and three-fold methyl-substituted derivatives, however (compound **19** and **45**, [Figure 5](#molecules-18-08799-f005){ref-type="fig"}C,D) exhibit reduced activity.

![HQSAR contribution of molecular fragments to the inhibition of \[^3^H\]8-OH-DPAT binding; 2 examples for potent compounds **16** (**A**) and **40** (**B**) and 2 examples for weak compounds **19** (**C**) and **45** (**D**) are given.](molecules-18-08799-g005){#molecules-18-08799-f005}

Individual atomic contributions of OH, OMe and CONH~2~ substituents at position 5 (most active compounds **15**, **16** ([Figure 5](#molecules-18-08799-f005){ref-type="fig"}A), **17** and **40** ([Figure 5](#molecules-18-08799-f005){ref-type="fig"} B) are strongly associated with the biological activity of these compounds. The green and yellow colored pattern indicates their favorable contribution to the activity. Combined with a 2-methyl substitution, positions 5, 6 and 7 containing alkyl groups are strongly disfavoring activity, as it is shown by orange and red colored patterns. The modification of positions 4, 5, 6 and 7 with halogen substituents should be especially focused in order to improve the inhibitory activities of Ts.

3. Experimental
===============

3.1. Data Set
-------------

Several Ts inhibit at micromolar concentration the four binding sites (5-HT~2A~ site, 5-HT~1A~ site, NMDA channel and polyamine-modulated NMDA channel). The affinities of 64 Ts (from sources as described \[[@B19-molecules-18-08799]\]) at the NMDA channel were obtained from the inhibition of specific binding of the radioligand \[^3^H\]MK-801 (5 nM) to membranes prepared from hippocampal and parietal cortex of male Wistar rats. As reported previously \[[@B17-molecules-18-08799]\], the potency of most Ts as inhibitors of \[^3^H\]MK-801 binding was reduced by the polyamine spermine (10 mM Tris acetate buffer pH 7.0, 30 µM spermine). The affinities at 5-HT~2A~ receptors were obtained from the inhibition of specific binding of \[^3^H\]ketanserin (1 nM) to rat prefrontal cortex membranes. In addition, 47 Ts were tested at 5-HT~1A~ receptors, as inhibitors of \[^3^H\]8-OH-DPAT binding (1 nM) to rat hippocampal membranes. Chemical structures together with experimental inhibition potencies are listed in [Table A](#molecules-18-08799-t005){ref-type="table"} (see [appendix](#app1-molecules-18-08799){ref-type="app"}).

At the chosen neutral pH, all Ts were in the protonated form. Concentrations of Ts providing 50% inhibition (IC~50~ values) were transferred to the corresponding pIC~50~ (--log IC~50~) values and used as dependent variables in the HQSAR analysis. In our previous work \[[@B19-molecules-18-08799]\], we published an extended description of the data set together with the discussion of detailed pharmacological investigations.

3.2. HQSAR Analysis
-------------------

The HQSAR modeling analyses, calculations and visualizations were performed using the SYBYL-X 1.0 package (Tripos Inc., St. Louis, MO, USA). HQSAR is a technique which employs fragment fingerprints as predictive variables of biological activity. These molecular fingerprints are broken into strings at fixed intervals as specified by the hologram length. The generation of the molecular fragments was carried out using several combinations of the following fragment distinction parameters: atoms (A), bonds (B), connections (C), hydrogen atoms (H), chirality (CH), and donor & acceptor (DA). Several combinations of these parameters were considered using fragment size of default 4--7. Each unique fragment in the data set is assigned a large positive integer by means of a cyclic redundancy check (CRC) algorithm. Each integer corresponds to a bin in an integer array of fixed length L (usually within 12 default hologram lengths of 53, 59, 61, 71, 83, 97, 151, 199, 257, 307, 353, and 401 bins). Thus, all generated fragments are hashed into array bins in the range of 1 to L. This array now constitutes a molecular hologram, the bin occupancies being the descriptor values. The following standard PLS analysis identifies a set of explanatory variables \[[@B20-molecules-18-08799],[@B21-molecules-18-08799],[@B22-molecules-18-08799]\].

4. Conclusions
==============

By using the holographic QSAR method, four correlation equations with high statistical quality and predictive value could be established. The visualization of the results by contribution maps with special color codings reflects, which combinations of molecular fragments are essentially contributing to the recognition of the NMDA and two 5-HT receptors by Ts.
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###### 

Structures and experimental pIC~50~ values (M), inhibiting the binding of \[^3^H\]MK-801 in absence and presence of 30 µM spermine, and the binding of \[^3^H\]ketanserin and of \[^3^H\]8-OH-DPAT, for a series of Ts. Data are logarithmic transformations of the IC~50~ values published previously \[[@B19-molecules-18-08799]\].

  No   Molecular name      pIC~50~                 
  ---- ------------------- --------- ------ ------ ------
  1    tryptamine          4.07      3.32   4.79   6.48
  2    homo-T              4.30      3.54   5.12   6.15
  3    1-Me-T              4.27      3.37   5.10   6.11
  4    2-Me-T              4.96      4.56   4.52   5.81
  5    5-Me-T              5.19      5.05   5.00   7.21
  6    5-Bu-T              4.82      4.18   5.12   7.15
  7    6-Me-T              3.95      3.37   4.34   5.41
  8    7-Me-T              4.34      3.56   4.75   5.75
  9    α-Me-T              3.62      2.82   4.90   5.80
  10   N-Me-T              3.42      2.68   4.91   7.00
  11   5-F-T               4.41      3.67   5.21   6.81
  12   5-F-hT              4.18      3.34   5.51   6.41
  13   5-Cl-T              4.75      3.92   5.17   7.06
  14   5-Br-hT             5.13      4.10   5.64   7.49
  15   5-OH-T              3.76      3.22   5.27   8.80
  16   5-MeO-T             4.72      3.75   4.97   8.23
  17   5-NH~2~CO-T         3.66      3.24   3.80   9.82
  18   1,2-Me~2~-T         4.79      3.84   4.83   5.84
  19   2,5-Me~2~-T         5.43      4.69   4.80   4.77
  20   2-Me-5-Et-T         5.81      4.72   5.03   5.28
  21   2-Me-5-Bu-T         4.91      4.05   5.08   \-
  22   2-Me-5-iBu-T        5.22      4.18   5.20   5.60
  23   2-Me-5CN-T          4.66      3.53   3.76   5.40
  24   2-Me-5-F-T          4.95      4.25   4.66   5.36
  25   2-Me-5-Cl-T         5.45      4.41   5.24   5.11
  26   2-Me-5-Br-T         5.60      4.65   5.35   5.75
  27   2-Me-5-I-T          5.64      4.86   5.27   6.26
  28   2-Me-5-OH-T         4.27      3.35   3.72   5.67
  29   2-Me-5-MeO-T        5.28      4.29   4.28   5.95
  30   2,7-Me~2~-T         3.81      3.20   4.75   5.28
  31   2-Me-7-CF~3~-T      4.05      3.26   5.48   \-
  32   2-Me-7-Et-T         4.00      3.35   4.74   \-
  33   2-Me-7-iPrp-T       4.39      3.64   4.69   5.39
  34   2-Me-7-F-T          4.74      4.05   4.83   \-
  35   2-Me-7-Cl-T         4.38      3.75   5.54   5.69
  36   2-Me-7-Br-T         4.21      3.45   5.51   \-
  37   2-Me-7-I-T          4.43      3.75   5.52   \-
  38   5-Me-7-Br-T         4.68      4.00   5.37   6.01
  39   α -Me-5-F-T         4.19      3.31   5.15   5.90
  40   α -Me-5-OH-T        3.17      2.39   5.09   7.41
  41   4,6-Cl~2~-T         4.32      3.83   5.26   5.74
  42   2,4,6-Me~3~-T       3.61      3.31   4.28   \-
  43   2,4,7-Me~3~-T       3.74      3.09   5.38   5.54
  44   2,5,7-Me~3~-T       4.20      3.29   4.74   4.84
  45   2,6,7-Me~3~-T       4.15      3.30   4.75   5.07
  46   2,5-Me~2--7~-Br-T   4.41      3.68   5.47   \-
  47   2,7-Me~2--4~-F-T    5.26      4.54   5.48   6.00
  48   2,7-Me~2--4~-Cl-T   3.90      3.45   5.69   6.29
  49   2,7-Me~2--5~-Cl-T   4.52      3.75   5.12   \-
  50   2,7-Me~2--6~-Cl-T   4.33      3.55   4.90   \-
  51   2-Me-5-Br-7-Et-T    4.43      3.88   5.03   \-
  52   2-Me-5,7-F~2~-T     4.84      3.99   5.24   \-
  53   2-Me-4,7-Cl~2~-T    4.41      3.88   5.92   6.37
  54   2-Me-5,7-Cl~2~-T    4.63      3.94   5.28   \-
  55   2-Me-6,7-Cl~2~-T    4.60      3.88   5.43   \-
  56   2-Me-4,7-Br~2~-T    4.47      4.06   5.55   6.76
  57   2-Me-5-F-7-Br-T     4.41      3.64   5.35   \-
  58   2-Me-5-Br-7-F-T     5.57      4.81   5.24   5.56
  59   2-Me-5-Cl-7-Br-T    4.94      4.16   5.14   \-
  60   2-Me-5,7-Br~2~-T    4.87      4.18   5.39   \-
  61   L-Trp-Me            3.86      2.90   4.40   4.80
  62   D-Trp-Me            3.24      2.37   4.44   3.96
  63   L-Trp-NH~2~         4.08      3.05   2.96   3.08
  64   Trp-Oct             4.71      4.23   5.05   4.36

T, tryptamine; hT, homotryptamine \[3-(1*H*-indol-3-yl)propan-1-amine\]; - , not measured.
